Bilgin Murat, Akkaya Emre, Dokuyucu Recep
Department of Cardiology, Private Aktif International Hospital, Yalova 77720, Turkey.
Department of Cardiology, Bossan Hospital, Gaziantep 27580, Turkey.
J Clin Med. 2024 Oct 6;13(19):5940. doi: 10.3390/jcm13195940.
: Non-ST-elevation myocardial infarction (NSTEMI) is characterized by the absence of pathological ST segment elevation but an increase in biological markers. The SYNTAX II score (SS-II) is calculated to evaluate the complexity of coronary artery disease and to guide treatment decisions between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). The aim of this study is to evaluate the relationship of socio-demographic data and biochemical markers with SS-II in NSTEMI patients. : Six hundred patients who were admitted to the private Aktif International Hospital cardiology clinic between January 2020 and January 2024 and were diagnosed with NSTEMI were included in the study. Severity, extent, and clinical evaluation of atherosclerosis were determined using risk factors, laboratory tests, and coronary angiography. Patients were divided into two groups according to their SS-II score: low (≤ 22) and high SS-II (> 32). Socio-demographic data, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and monocyte-to-HDL-C ratio (MHR) were compared between the two groups. : Group 1 (SS-II ≤ 22) included 380 patients, and group 2 (SS-II > 32) included 220 patients. There was a statistically significant difference in HDL, creatine value, white blood cell, troponin I, hs-TnT, and monocyte values in group 2 compared with group 1 ( = 0.001, = 0.018, = 0.031, and = 0.001, respectively). NLR, MLR, MHR, and SS values were statistically significantly higher in group 2 compared with group 1 ( = 0.015, = 0.002, = 0.001, and = 0.001, respectively). The risk factors were found to be significantly associated with high-risk NSTEMI (SS-II > 32) in a logistic regression analysis and included peripheral artery disease (PAD) (OR: 3.028, = 0.040), troponin I (OR: 3.575, = 0.015), hs-TnT (OR: 4.221, = 0.010), NLR (OR: 1.528, = 0.024). MLR (OR: 5.248, = 0.012), and MHR (OR: 7.122, = 0.010). ROC analysis revealed that NLR (AUC: 0.691, = 0.016), MLR (AUC: 0.731, = 0.004), and MHR (AUC: 0.824, = 0.003) had higher predictive power than other parameters in patients with high-risk NSTEMI (SS-II > 32). : We found that NLR, MLR, and MHR levels are associated with the severity of coronary artery disease. We think that adding these easily and quickly measurable parameters to routine laboratory results may support the clinician in evaluating the complexity of coronary artery disease and guiding treatment decisions in NSTEMI patients.
非ST段抬高型心肌梗死(NSTEMI)的特征是无病理性ST段抬高,但生物标志物升高。计算SYNTAX II评分(SS-II)以评估冠状动脉疾病的复杂性,并指导经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)之间的治疗决策。本研究的目的是评估NSTEMI患者的社会人口统计学数据和生化标志物与SS-II之间的关系。
2020年1月至2024年1月期间入住私立阿克蒂夫国际医院心脏病科门诊且被诊断为NSTEMI的600例患者纳入本研究。使用危险因素、实验室检查和冠状动脉造影确定动脉粥样硬化的严重程度、范围和临床评估。根据患者的SS-II评分将其分为两组:低评分组(≤22)和高评分组(>32)。比较两组患者的社会人口统计学数据、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)以及单核细胞与高密度脂蛋白胆固醇比值(MHR)。
第1组(SS-II≤22)包括380例患者,第2组(SS-II>32)包括220例患者。与第1组相比,第2组的高密度脂蛋白、肌酸值、白细胞、肌钙蛋白I、高敏肌钙蛋白T和单核细胞值存在统计学显著差异(分别为P = 0.001、P = 0.018、P = 0.031和P = 0.001)。与第1组相比,第2组的NLR、MLR、MHR和SS值在统计学上显著更高(分别为P = 0.015、P = 0.002、P = 0.001和P = 0.001)。在逻辑回归分析中发现,危险因素与高危NSTEMI(SS-II>32)显著相关,包括外周动脉疾病(PAD)(比值比:3.028,P = 0.040)、肌钙蛋白I(比值比:3.575,P = 0.015)、高敏肌钙蛋白T(比值比:4.221, P = 0.010)、NLR(比值比:1.528,P = 0.024)、MLR(比值比:5.248,P = 0.